Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus

Journal of Neuroendocrinology

Volumn 9, Issue 4, 1997, Pages 263-269

  Nicot, Arnaud ^a   Rowe, Wayne B ^b   De Kloet, E Ronald ^c   Betancur, Catalina ^a   Jessop, David S ^d   Lightman, Stafford L ^d   Quirion, Rémi ^b   Rostène, William ^a,e   Bérod, Anne ^a  

^a INSERM   (France)

^b MCGILL UNIVERSITY   (Canada)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

ACTH; Corticosterone; Corticotropin releasing hormone; HPA axis; mRNA; Peptide; Vasopressin

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; CORTICOSTERONE; CORTICOTROPIN; MESSENGER RNA; NEUROPEPTIDE; NEUROTENSIN; OXYTOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; GIANT CELL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN SITU HYBRIDIZATION; INTRACEREBRAL DRUG ADMINISTRATION; NONHUMAN; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; STRESS; THALAMUS MIDLINE NUCLEUS; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

EID: 0030963350     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00581.x     Document Type: Article

References (45)

1. Nemeroff CB. New vistas in neuropeptide research in neuropsychiatry: Focus on corticotropin-releasing factor. Neuropharmacology 1992; 6: 69-75.
2. Barden N, Reul JMH, Holsboer F. Do antidepressant stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995; 18: 6-14.
3. O'Dwyer AM, Lightman SL, Marks MN, Checkley SA. Treatment of major depression with metyrapone and hydrocortisone. J Affect Dis 1995; 33: 123-128.
4. Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J Clin Invest 1991; 87: 831-837.
5. Reul JMH, Stec I, Söder M, Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 1993; 133: 312-320.
6. Lightman SL, Young III WS. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J Physiol 1988; 403: 511-523.
7. Herman JP, Schäfer MKH, Sladek CD, Day R, Young EA, Akil H, Watson SJ. Chronic electroconvulsive shock treatment elicits up-regulation of CRF and VP mRNA in select populations of neuroendocrine neurons. Brain Res 1989; 501: 235-246.
8. Harbuz MS, Lightman SL. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 1989; 122: 705-711.
9. Imaki T, Nahon JL, Rivier C, Sawchenko PE, Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 1991; 11: 585-599.
10. Bartanusz V, Jezova D, Bertini LC, Tilders FJH, Aubry JM, Kiss JZ. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 1993; 132: 895-902.
11. Kwak SP, Morano I, Young EA, Watson SJ, Akil H. Diurnal CRH mRNA rhythm in the hypothalamus: decreased expression in the evening is not dependent on endogenous glucocorticoids. Neuroendocrinology 1993; 57: 96-105.
12. Sawchenko PE, Arias CA, Mortrud MT. Local tetrodotoxin blocks chronic stress effects on corticotropin-releasing factor and vasopressin messenger ribonucleic acids in hypophysiotrophic neurons. J Neuroendocrinol 1993; 5: 341-348.
13. Rotsztejn WH, Beaudet A, Roberge AG, Lalonde J, Fortier C. Role of brain serotonin in the circadian rhythm of corticosterone secretion and the corticotropic response to adrenalectomy in the rat. Neuroendocrinology 1977; 23: 157-170.
14. Szafarczyk A, Alonso G, Ixart G, Malaval F, Assenmacher I. Diurnal-stimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am J Physiol 1985; 249: E219-226.
15. Szafarczyk A, Ixart G, Malaval F, Nouguier-Soulé J, Assenmacher I. Effects of lesions of the suprachiasmatic nuclei and of p-chlorophenylalanine on the circadian rhythms of adrenocorticotrophic hormone and corticosterone in the plasma, and on locomotor activity of rats. J Endocrinol 1979; 83: 1-16.
16. Scaccianoce S, Cigliana G, Musculo LAA, Porcu A, Navara D, Perez-Polo JR, Angelucci L. Hypothalamic involvement in the activation of the pituitary-adrenocortical axis by nerve growth factor. Neuroendocrinology 1993; 58: 202-209.
17. Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Mol Brain Res 1993; 18: 311-315.
18. Larsen PJ, Jessop DS, Patel H, Lightman SL, Chowdrey HS. Substance P inhibits the release of anterior pituitary adrenocorticotropin via a central mechanism involving corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J Neuroendoc 1993; 5: 99-105;
19. Carraway RE, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973; 248: 6854-6861.
20. Fuxe K, Agnati L, Andersson K, Eneroth P, Härfstrand A, Golstein M, Zoli M. Studies on neurotensin-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Neurochem Int 1984; 6: 737-750.
21. Gudelsky GA, Berry SA, Meltzer HY. Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Neuroendocrinology 1989; 49: 604-609.
22. Nicot A, Bérod A, Gully D, Rowe W, Quirion R, De Kloet ER, Rostène W. Blockade of neurotensin binding in the rat hypothalamus and of central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non peptide receptor antagonists. Neuroendocrinology 1994; 59: 572-578.
23. Moga MM, Saper CB. Neuropeptide-immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat. J Comp Neurol 1994; 346: 137-150.
24. Antoni FE. Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Rev 1986; 7: 351-378.
25. Rowe W, Viau V, Meaney MJ, Quirion R. Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: Evidence for the participation of the paraventricular nucleus. J Neuroendocrinol 1995; 7: 109-117.
26. Rowe W, Nicot A, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R. Central administration of the neurotensin receptor antagonist, SR 48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity. Neuroendocrinology, 1996; (in press).
27. Herman JP, Wiegand SJ, Watson SJ. Regulation of basal corticotropin releasing factor and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 1990; 127: 2408-2417.
28. Baldino F, Jr, O'Kane TM, Fitzpatrick-McElligott S, Wolson B. Coordinate hormonal and synaptic regulation of vasopressin messenger RNA. Science 1988; 241: 978-981.
29. Wu P, Childs GV. Cold and novel environment stress affects VP mRNA in the paraventricular nucleus, but not the supraoptic nucleus: An in situ hybridisation study. Mol Cell Neurosci 1990; 1: 233-249.
30. Dohanics J, Hoffman GE, Verbalis JG. Hyponatremia-induced inhibition of magnocellular neurons causes stressor-selective impairment of stimulated adrenocorticotropin secretion in rats. Endocrinology 1991; 128: 331-340.
31. 125I]Tyr3-neurotensin. Neuroscience 1987; 22: 525-536.
32. Kikpatrick K, Bourque CW. Effects of neurotensin on rat supraoptic nucleus neurones in vitro. J Physiol 1995; 482: 373-381.
33. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, Pélaprat D, Labbé-Jullié C, Mazella J, Maffrand JP, Rostène W, Kitabgi P, Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci USA 1993; 90: 65-69.
34. Sawchenko PE. Evidence for a local site for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res 1987; 403: 213-224.
35. Kovacs K, Kiss JK, Makara GB. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing-factor and arginin vasopressin immunoreactivity induced by adrenalectomy. Neuroendocrinology 1986; 44: 229-234.
36. Gomez F, Lahmame A, De Kloet ER, Armario A. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996; 63: 327-337.
37. Van Eekelen JAM, Oitzl MS, De Kloet ER. Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male brown norway rats. J Gerontology 1995; 50A: B83-B89.
38. Rots NY, Cools AR, Oitzl MS, de Jong J, Sutanto W, De Kloet ER. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness. Endocrinology 1996; 137: 1678-1686.
39. Veldhuis HD, van Koppen C, van Ittersum M, de Kloet ER. Specificity of the adrenal steroid receptor system in rat hippocampus. Endocrinology 1982; 110: 2044-2047.
40. Sweep CJJ, van der Meer MJS, Hermus ARMM, Smals AGH, van der Meer JWM, Pesman GJ, Willemsen SJ, Benraad TJ, Kloppenborg PWC. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1β infusion: in vivo and in vitro studies. Endocrinology 1992; 130: 1153-1164.
41. Rooke P, Baylis PH. A new sensitive radioimmunoassay for plasma arginine vasopressin. J Immunoassay 1982; 3: 115-120.
42. Robinson IC. The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in unextracted plasma. J Immunoassay 1980; 1: 323-347.
43. Jingami H, Mizuno N, Takahashi H, Shibahara S, Furutani Y, Imura H, Numa S. Cloning and sequence analysis of cDNA for rat corticotropin-releasing factor precursor. FEBS Lett 1985; 191: 63-66.
44. Ivell R, Richter D. Structure and comparison of the oxytocin and vasopressin genes from the rat. Proc Natl Acad Sci USA 1984; 91: 2006-2010.
45. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press, 1986: 2nd ed.